Medra Corporation
MDRA · OTC
6/30/2002 | 3/31/2002 | 12/31/2001 | 9/30/2001 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -9.2% | -55.1% | 87.9% | – |
| Cost of Goods Sold | $0 | $0 | $1 | $0 |
| Gross Profit | -$0 | $0 | -$0 | $0 |
| % Margin | -126% | 8% | -36.2% | 29.5% |
| R&D Expenses | $0 | $0 | $1 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | -$3 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$4 | -$3 | $0 | -$4 |
| Operating Expenses | -$2 | -$1 | -$2 | -$2 |
| Operating Income | $2 | $1 | $2 | $2 |
| % Margin | 1,004.2% | 702.9% | 469.4% | 893.6% |
| Other Income/Exp. Net | -$2 | -$1 | -$2 | -$2 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$1 | -$2 | -$2 |
| % Margin | -1,012.2% | -697% | -472.4% | -899.4% |
| EPS | -50 | -40 | -68.2 | -80 |
| % Growth | -25% | 41.3% | 14.7% | – |
| EPS Diluted | -50 | -40 | -68.2 | -80 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | -$0 | $0 |
| EBITDA | -$2 | -$1 | -$2 | -$2 |
| % Margin | -837.1% | -676.7% | -477.8% | -845% |